1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Remicade Biosimilar Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 100mg/10ml 1.2.3 500mg/50ml 1.3 Market Segment by Application 1.3.1 Global Remicade Biosimilar Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Blood Disorders 1.3.3 Oncology Diseases 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Remicade Biosimilar Market Size (2017-2028) 2.1.1 Global Remicade Biosimilar Revenue (2017-2028) 2.1.2 Global Remicade Biosimilar Sales (2017-2028) 2.2 Global Remicade Biosimilar Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Remicade Biosimilar Sales by Regions (2017-2022) 2.2.2 Global Remicade Biosimilar Revenue by Regions (2017-2022) 2.3 Global Remicade Biosimilar Market Size Forecast by Region 2.3.1 Global Remicade Biosimilar Sales Forecast by Region (2023-2028) 2.3.2 Global Remicade Biosimilar Revenue Forecast by Region (2023-2028) 2.4 Global Top Remicade Biosimilar Regions (Countries) Ranking by Market Size 2.5 Remicade Biosimilar Market Dynamics 2.5.1 Remicade Biosimilar Market Trends 2.5.2 Remicade Biosimilar Market Drivers 2.5.3 Remicade Biosimilar Market Challenges 2.5.4 Remicade Biosimilar Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Remicade Biosimilar Manufacturers by Sales (2017-2022) 3.1.1 Global Remicade Biosimilar Sales by Manufacturers (2017-2022) 3.1.2 Global Remicade Biosimilar Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Remicade Biosimilar Sales in 2021 3.2 Global Top Manufacturers Remicade Biosimilar by Revenue 3.2.1 Global Remicade Biosimilar Revenue by Manufacturers (2017-2022) 3.2.2 Top Remicade Biosimilar Manufacturers Covered: Ranking by Revenue 3.2.3 Global Remicade Biosimilar Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Remicade Biosimilar as of 2021) 3.4 Global Remicade Biosimilar Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Remicade Biosimilar Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Remicade Biosimilar Market 3.7 Key Manufacturers Remicade Biosimilar Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Remicade Biosimilar Market Size by Type 4.1 Global Remicade Biosimilar Historic Market Review by Type (2017-2022) 4.1.1 Global Remicade Biosimilar Sales Market Share by Type (2017-2022) 4.1.2 Global Remicade Biosimilar Revenue Market Share by Type (2017-2022) 4.1.3 Remicade Biosimilar Price by Type (2017-2022) 4.2 Global Remicade Biosimilar Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Remicade Biosimilar Sales Forecast by Type (2023-2028) 4.2.2 Global Remicade Biosimilar Revenue Forecast by Type (2023-2028) 4.2.3 Remicade Biosimilar Price Forecast by Type (2023-2028) 5 Global Remicade Biosimilar Market Size by Application 5.1 Global Remicade Biosimilar Historic Market Review by Application (2017-2022) 5.1.1 Global Remicade Biosimilar Sales Market Share by Application (2017-2022) 5.1.2 Global Remicade Biosimilar Revenue Market Share by Application (2017-2022) 5.1.3 Remicade Biosimilar Price by Application (2017-2022) 5.2 Global Remicade Biosimilar Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Remicade Biosimilar Sales Forecast by Application (2023-2028) 5.2.2 Global Remicade Biosimilar Revenue Forecast by Application (2023-2028) 5.2.3 Remicade Biosimilar Price Forecast by Application (2023-2028) 6 North America 6.1 North America Remicade Biosimilar Sales Breakdown by Company 6.1.1 North America Remicade Biosimilar Sales by Company (2017-2022) 6.1.2 North America Remicade Biosimilar Revenue by Company (2017-2022) 6.2 North America Remicade Biosimilar Market Size by Type 6.2.1 North America Remicade Biosimilar Sales by Type (2017-2028) 6.2.2 North America Remicade Biosimilar Revenue by Type (2017-2028) 6.3 North America Remicade Biosimilar Market Size by Application 6.3.1 North America Remicade Biosimilar Sales by Application (2017-2028) 6.3.2 North America Remicade Biosimilar Revenue by Application (2017-2028) 6.4 North America Remicade Biosimilar Market Size by Country 6.4.1 North America Remicade Biosimilar Sales by Country (2017-2028) 6.4.2 North America Remicade Biosimilar Revenue by Country (2017-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Remicade Biosimilar Sales Breakdown by Company 7.1.1 Europe Remicade Biosimilar Sales by Company (2017-2022) 7.1.2 Europe Remicade Biosimilar Revenue by Company (2017-2022) 7.2 Europe Remicade Biosimilar Market Size by Type 7.2.1 Europe Remicade Biosimilar Sales by Type (2017-2028) 7.2.2 Europe Remicade Biosimilar Revenue by Type (2017-2028) 7.3 Europe Remicade Biosimilar Market Size by Application 7.3.1 Europe Remicade Biosimilar Sales by Application (2017-2028) 7.3.2 Europe Remicade Biosimilar Revenue by Application (2017-2028) 7.4 Europe Remicade Biosimilar Market Size by Country 7.4.1 Europe Remicade Biosimilar Sales by Country (2017-2028) 7.4.2 Europe Remicade Biosimilar Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Remicade Biosimilar Sales Breakdown by Company 8.1.1 Asia Pacific Remicade Biosimilar Sales by Company (2017-2022) 8.1.2 Asia Pacific Remicade Biosimilar Revenue by Company (2017-2022) 8.2 Asia Pacific Remicade Biosimilar Market Size by Type 8.2.1 Asia Pacific Remicade Biosimilar Sales by Type (2017-2028) 8.2.2 Asia Pacific Remicade Biosimilar Revenue by Type (2017-2028) 8.3 Asia Pacific Remicade Biosimilar Market Size by Application 8.3.1 Asia Pacific Remicade Biosimilar Sales by Application (2017-2028) 8.3.2 Asia Pacific Remicade Biosimilar Revenue by Application (2017-2028) 8.4 Asia Pacific Remicade Biosimilar Market Size by Region 8.4.1 Asia Pacific Remicade Biosimilar Sales by Region 8.4.2 Asia Pacific Remicade Biosimilar Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 China Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 9 Latin America 9.1 Latin America Remicade Biosimilar Sales Breakdown by Company 9.1.1 Latin America Remicade Biosimilar Sales by Company (2017-2022) 9.1.2 Latin America Remicade Biosimilar Revenue by Company (2017-2022) 9.2 Latin America Remicade Biosimilar Market Size by Type 9.2.1 Latin America Remicade Biosimilar Sales by Type (2017-2028) 9.2.2 Latin America Remicade Biosimilar Revenue by Type (2017-2028) 9.3 Latin America Remicade Biosimilar Market Size by Application 9.3.1 Latin America Remicade Biosimilar Sales by Application (2017-2028) 9.3.2 Latin America Remicade Biosimilar Revenue by Application (2017-2028) 9.4 Latin America Remicade Biosimilar Market Size by Country 9.4.1 Latin America Remicade Biosimilar Sales by Country (2017-2028) 9.4.2 Latin America Remicade Biosimilar Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Remicade Biosimilar Sales Breakdown by Company 10.1.1 Middle East and Africa Remicade Biosimilar Sales by Company (2017-2022) 10.1.2 Middle East and Africa Remicade Biosimilar Revenue by Company (2017-2022) 10.2 Middle East and Africa Remicade Biosimilar Market Size by Type 10.2.1 Middle East and Africa Remicade Biosimilar Sales by Type (2017-2028) 10.2.2 Middle East and Africa Remicade Biosimilar Revenue by Type (2017-2028) 10.3 Middle East and Africa Remicade Biosimilar Market Size by Application 10.3.1 Middle East and Africa Remicade Biosimilar Sales by Application (2017-2028) 10.3.2 Middle East and Africa Remicade Biosimilar Revenue by Application (2017-2028) 10.4 Middle East and Africa Remicade Biosimilar Market Size by Country 10.4.1 Middle East and Africa Remicade Biosimilar Sales by Country (2017-2028) 10.4.2 Middle East and Africa Remicade Biosimilar Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 Synthon Pharmaceuticals 11.1.1 Synthon Pharmaceuticals Corporation Information 11.1.2 Synthon Pharmaceuticals Overview 11.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products and Services 11.1.5 Synthon Pharmaceuticals Remicade Biosimilar SWOT Analysis 11.1.6 Synthon Pharmaceuticals Recent Developments 11.2 LG Life Sciences 11.2.1 LG Life Sciences Corporation Information 11.2.2 LG Life Sciences Overview 11.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 LG Life Sciences Remicade Biosimilar Products and Services 11.2.5 LG Life Sciences Remicade Biosimilar SWOT Analysis 11.2.6 LG Life Sciences Recent Developments 11.3 Novartis (Sandoz) 11.3.1 Novartis (Sandoz) Corporation Information 11.3.2 Novartis (Sandoz) Overview 11.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Novartis (Sandoz) Remicade Biosimilar Products and Services 11.3.5 Novartis (Sandoz) Remicade Biosimilar SWOT Analysis 11.3.6 Novartis (Sandoz) Recent Developments 11.4 Celltrion 11.4.1 Celltrion Corporation Information 11.4.2 Celltrion Overview 11.4.3 Celltrion Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 Celltrion Remicade Biosimilar Products and Services 11.4.5 Celltrion Remicade Biosimilar SWOT Analysis 11.4.6 Celltrion Recent Developments 11.5 Biocon 11.5.1 Biocon Corporation Information 11.5.2 Biocon Overview 11.5.3 Biocon Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Biocon Remicade Biosimilar Products and Services 11.5.5 Biocon Remicade Biosimilar SWOT Analysis 11.5.6 Biocon Recent Developments 11.6 Hospira 11.6.1 Hospira Corporation Information 11.6.2 Hospira Overview 11.6.3 Hospira Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 Hospira Remicade Biosimilar Products and Services 11.6.5 Hospira Remicade Biosimilar SWOT Analysis 11.6.6 Hospira Recent Developments 11.7 Merck Serono (Merck Group) 11.7.1 Merck Serono (Merck Group) Corporation Information 11.7.2 Merck Serono (Merck Group) Overview 11.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products and Services 11.7.5 Merck Serono (Merck Group) Remicade Biosimilar SWOT Analysis 11.7.6 Merck Serono (Merck Group) Recent Developments 11.8 Biogen idec Inc. 11.8.1 Biogen idec Inc. Corporation Information 11.8.2 Biogen idec Inc. Overview 11.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Biogen idec Inc. Remicade Biosimilar Products and Services 11.8.5 Biogen idec Inc. Remicade Biosimilar SWOT Analysis 11.8.6 Biogen idec Inc. Recent Developments 11.9 Genentech (Roche Group) 11.9.1 Genentech (Roche Group) Corporation Information 11.9.2 Genentech (Roche Group) Overview 11.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Genentech (Roche Group) Remicade Biosimilar Products and Services 11.9.5 Genentech (Roche Group) Remicade Biosimilar SWOT Analysis 11.9.6 Genentech (Roche Group) Recent Developments 11.10 Fosun Pharmaceutical 11.10.1 Fosun Pharmaceutical Corporation Information 11.10.2 Fosun Pharmaceutical Overview 11.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 Fosun Pharmaceutical Remicade Biosimilar Products and Services 11.10.5 Fosun Pharmaceutical Remicade Biosimilar SWOT Analysis 11.10.6 Fosun Pharmaceutical Recent Developments 11.11 Livzon Pharmaceutical 11.11.1 Livzon Pharmaceutical Corporation Information 11.11.2 Livzon Pharmaceutical Overview 11.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.11.4 Livzon Pharmaceutical Remicade Biosimilar Products and Services 11.11.5 Livzon Pharmaceutical Recent Developments 11.12 Anke Biotechnology 11.12.1 Anke Biotechnology Corporation Information 11.12.2 Anke Biotechnology Overview 11.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.12.4 Anke Biotechnology Remicade Biosimilar Products and Services 11.12.5 Anke Biotechnology Recent Developments 11.13 Hualan Biological Engineering 11.13.1 Hualan Biological Engineering Corporation Information 11.13.2 Hualan Biological Engineering Overview 11.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.13.4 Hualan Biological Engineering Remicade Biosimilar Products and Services 11.13.5 Hualan Biological Engineering Recent Developments 11.14 Walvax Biotechnology 11.14.1 Walvax Biotechnology Corporation Information 11.14.2 Walvax Biotechnology Overview 11.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.14.4 Walvax Biotechnology Remicade Biosimilar Products and Services 11.14.5 Walvax Biotechnology Recent Developments 11.15 Hisun Pharmaceutical 11.15.1 Hisun Pharmaceutical Corporation Information 11.15.2 Hisun Pharmaceutical Overview 11.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.15.4 Hisun Pharmaceutical Remicade Biosimilar Products and Services 11.15.5 Hisun Pharmaceutical Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Remicade Biosimilar Value Chain Analysis 12.2 Remicade Biosimilar Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Remicade Biosimilar Production Mode & Process 12.4 Remicade Biosimilar Sales and Marketing 12.4.1 Remicade Biosimilar Sales Channels 12.4.2 Remicade Biosimilar Distributors 12.5 Remicade Biosimilar Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Remicade Biosimilar Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of 100mg/10ml Table 3. Major Manufacturers of 500mg/50ml Table 4. Global Remicade Biosimilar Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Remicade Biosimilar Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global Remicade Biosimilar Sales by Region (2017-2022) & (L) Table 7. Global Remicade Biosimilar Sales Market Share by Region (2017-2022) Table 8. Global Remicade Biosimilar Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Remicade Biosimilar Revenue Market Share by Region (2017-2022) Table 10. Global Remicade Biosimilar Sales Forecast by Region (2023-2028) & (L) Table 11. Global Remicade Biosimilar Sales Market Share Forecast by Region (2023-2028) Table 12. Global Remicade Biosimilar Revenue Forecast by Region (2023-2028) & (US$ Million) Table 13. Global Remicade Biosimilar Revenue Market Share Forecast by Region (2023-2028) Table 14. Top Remicade Biosimilar Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 15. Remicade Biosimilar Market Trends Table 16. Remicade Biosimilar Market Drivers Table 17. Remicade Biosimilar Market Challenges Table 18. Remicade Biosimilar Market Restraints Table 19. Global Remicade Biosimilar Sales by Manufacturers (2017-2022) & (L) Table 20. Global Remicade Biosimilar Sales Share by Manufacturers (2017-2022) Table 21. Global Remicade Biosimilar Revenue by Manufacturers (2017-2022) & (US$ Million) Table 22. Ranking of Global Top Remicade Biosimilar Manufacturers by Revenue (US$ Million) in 2021 Table 23. Remicade Biosimilar Revenue Share by Manufacturers (2017-2022) Table 24. Global Remicade Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Remicade Biosimilar as of 2021) Table 26. Key Manufacturers Remicade Biosimilar Average Selling Price (ASP) & (2017-2022) & (US$/Ml) Table 27. Key Manufacturers Remicade Biosimilar Plants/Factories Distribution Table 28. Key Manufacturers Remicade Biosimilar Area Served Table 29. Date of Key Manufacturers Enter into Remicade Biosimilar Market Table 30. Key Manufacturers Remicade Biosimilar Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Remicade Biosimilar Sales (L) by Type (2017-2022) Table 33. Global Remicade Biosimilar Sales Share by Type (2017-2022) Table 34. Global Remicade Biosimilar Revenue (US$ Million) Market Share by Type (2017-2022) Table 35. Global Remicade Biosimilar Price (L) by Type (2017-2022) Table 36. Global Remicade Biosimilar Sales (L) by Type (2023-2028) Table 37. Global Remicade Biosimilar Sales Share by Type (2023-2028) Table 38. Global Remicade Biosimilar Revenue (US$ Million) Market Share by Type (2023-2028) Table 39. Global Remicade Biosimilar Revenue Share by Type (2023-2028) Table 40. Global Remicade Biosimilar Price (L) by Type (2023-2028) Table 41. Global Remicade Biosimilar Sales (L) by Application (2017-2022) Table 42. Global Remicade Biosimilar Sales Share by Application (2017-2022) Table 43. Global Remicade Biosimilar Revenue (US$ Million) Market Share by Application (2017-2022) Table 44. Global Remicade Biosimilar Price (L) by Application (2017-2022) Table 45. Global Remicade Biosimilar Sales (L) by Application (2023-2028) Table 46. Global Remicade Biosimilar Sales Share by Application (2023-2028) Table 47. Global Remicade Biosimilar Revenue (US$ Million) Market Share by Application (2023-2028) Table 48. Global Remicade Biosimilar Revenue Share by Application (2023-2028) Table 49. Global Remicade Biosimilar Price (L) by Application (2023-2028) Table 50. North America Remicade Biosimilar Sales by Company (2017-2022) & (L) Table 51. North America Remicade Biosimilar Sales Market Share by Company (2017-2022) Table 52. North America Remicade Biosimilar Revenue by Company (2017-2022) & (US$ Million) Table 53. North America Remicade Biosimilar Revenue Market Share by Company (2017-2022) Table 54. North America Remicade Biosimilar Sales by Type (2017-2022) & (L) Table 55. North America Remicade Biosimilar Sales by Type (2023-2028) & (L) Table 56. North America Remicade Biosimilar Revenue by Type (2017-2022) & (US$ Million) Table 57. North America Remicade Biosimilar Revenue by Type (2023-2028) & (US$ Million) Table 58. North America Remicade Biosimilar Sales by Application (2017-2022) & (L) Table 59. North America Remicade Biosimilar Sales by Application (2023-2028) & (L) Table 60. North America Remicade Biosimilar Revenue by Application (2017-2022) & (US$ Million) Table 61. North America Remicade Biosimilar Revenue by Application (2023-2028) & (US$ Million) Table 62. North America Remicade Biosimilar Sales by Country (2017-2022) & (L) Table 63. North America Remicade Biosimilar Sales by Country (2023-2028) & (L) Table 64. North America Remicade Biosimilar Revenue by Country (2017-2022) & (US$ Million) Table 65. North America Remicade Biosimilar Revenue by Country (2023-2028) & (US$ Million) Table 66. Europe Remicade Biosimilar Sales by Company (2017-2022) & (L) Table 67. Europe Remicade Biosimilar Sales Market Share by Company (2017-2022) Table 68. Europe Remicade Biosimilar Revenue by Company (2017-2022) & (US$ Million) Table 69. Europe Remicade Biosimilar Revenue Market Share by Company (2017-2022) Table 70. Europe Remicade Biosimilar Sales by Type (2017-2022) & (L) Table 71. Europe Remicade Biosimilar Sales by Type (2023-2028) & (L) Table 72. Europe Remicade Biosimilar Revenue by Type (2017-2022) & (US$ Million) Table 73. Europe Remicade Biosimilar Revenue by Type (2023-2028) & (US$ Million) Table 74. Europe Remicade Biosimilar Sales by Application (2017-2022) & (L) Table 75. Europe Remicade Biosimilar Sales by Application (2023-2028) & (L) Table 76. Europe Remicade Biosimilar Revenue by Application (2017-2022) & (US$ Million) Table 77. Europe Remicade Biosimilar Revenue by Application (2023-2028) & (US$ Million) Table 78. Europe Remicade Biosimilar Sales by Country (2017-2022) & (L) Table 79. Europe Remicade Biosimilar Sales by Country (2023-2028) & (L) Table 80. Europe Remicade Biosimilar Revenue by Country (2017-2022) & (US$ Million) Table 81. Europe Remicade Biosimilar Revenue by Country (2023-2028) & (US$ Million) Table 82. Asia Pacific Remicade Biosimilar Sales by Company (2017-2022) & (L) Table 83. Asia Pacific Remicade Biosimilar Sales Market Share by Company (2017-2022) Table 84. Asia Pacific Remicade Biosimilar Revenue by Company (2017-2022) & (US$ Million) Table 85. Asia Pacific Remicade Biosimilar Revenue Market Share by Company (2017-2022) Table 86. Asia Pacific Remicade Biosimilar Sales by Type (2017-2022) & (L) Table 87. Asia Pacific Remicade Biosimilar Sales by Type (2023-2028) & (L) Table 88. Asia Pacific Remicade Biosimilar Revenue by Type (2017-2022) & (US$ Million) Table 89. Asia Pacific Remicade Biosimilar Revenue by Type (2023-2028) & (US$ Million) Table 90. Asia Pacific Remicade Biosimilar Sales by Application (2017-2022) & (L) Table 91. Asia Pacific Remicade Biosimilar Sales by Application (2023-2028) & (L) Table 92. Asia Pacific Remicade Biosimilar Revenue by Application (2017-2022) & (US$ Million) Table 93. Asia Pacific Remicade Biosimilar Revenue by Application (2023-2028) & (US$ Million) Table 94. Asia Pacific Remicade Biosimilar Sales by Region (2017-2022) & (L) Table 95. Asia Pacific Remicade Biosimilar Sales by Region (2023-2028) & (L) Table 96. Asia Pacific Remicade Biosimilar Revenue by Region (2017-2022) & (US$ Million) Table 97. Asia Pacific Remicade Biosimilar Revenue by Region (2023-2028) & (US$ Million) Table 98. Latin America Remicade Biosimilar Sales by Company (2017-2022) & (L) Table 99. Latin America Remicade Biosimilar Sales Market Share by Company (2017-2022) Table 100. Latin America Remicade Biosimilar Revenue by Company (2017-2022) & (US$ Million) Table 101. Latin America Remicade Biosimilar Revenue Market Share by Company (2017-2022) Table 102. Latin America Remicade Biosimilar Sales by Type (2017-2022) & (L) Table 103. Latin America Remicade Biosimilar Sales by Type (2023-2028) & (L) Table 104. Latin America Remicade Biosimilar Revenue by Type (2017-2022) & (US$ Million) Table 105. Latin America Remicade Biosimilar Revenue by Type (2023-2028) & (US$ Million) Table 106. Latin America Remicade Biosimilar Sales by Application (2017-2022) & (L) Table 107. Latin America Remicade Biosimilar Sales by Application (2023-2028) & (L) Table 108. Latin America Remicade Biosimilar Revenue by Application (2017-2022) & (US$ Million) Table 109. Latin America Remicade Biosimilar Revenue by Application (2023-2028) & (US$ Million) Table 110. Latin America Remicade Biosimilar Sales by Country (2017-2022) & (L) Table 111. Latin America Remicade Biosimilar Sales by Country (2023-2028) & (L) Table 112. Latin America Remicade Biosimilar Revenue by Country (2017-2022) & (US$ Million) Table 113. Latin America Remicade Biosimilar Revenue by Country (2023-2028) & (US$ Million) Table 114. Middle East and Africa Remicade Biosimilar Sales by Company (2017-2022) & (L) Table 115. Middle East and Africa Remicade Biosimilar Sales Market Share by Company (2017-2022) Table 116. Middle East and Africa Remicade Biosimilar Revenue by Company (2017-2022) & (US$ Million) Table 117. Middle East and Africa Remicade Biosimilar Revenue Market Share by Company (2017-2022) Table 118. Middle East and Africa Remicade Biosimilar Sales by Type (2017-2022) & (L) Table 119. Middle East and Africa Remicade Biosimilar Sales by Type (2023-2028) & (L) Table 120. Middle East and Africa Remicade Biosimilar Revenue by Type (2017-2022) & (US$ Million) Table 121. Middle East and Africa Remicade Biosimilar Revenue by Type (2023-2028) & (US$ Million) Table 122. Middle East and Africa Remicade Biosimilar Sales by Application (2017-2022) & (L) Table 123. Middle East and Africa Remicade Biosimilar Sales by Application (2023-2028) & (L) Table 124. Middle East and Africa Remicade Biosimilar Revenue by Application (2017-2022) & (US$ Million) Table 125. Middle East and Africa Remicade Biosimilar Revenue by Application (2023-2028) & (US$ Million) Table 126. Middle East and Africa Remicade Biosimilar Sales by Country (2017-2022) & (L) Table 127. Middle East and Africa Remicade Biosimilar Sales by Country (2023-2028) & (L) Table 128. Middle East and Africa Remicade Biosimilar Revenue by Country (2017-2022) & (US$ Million) Table 129. Middle East and Africa Remicade Biosimilar Revenue by Country (2023-2028) & (US$ Million) Table 130. Synthon Pharmaceuticals Corporation Information Table 131. Synthon Pharmaceuticals Description and Overview Table 132. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 133. Synthon Pharmaceuticals Remicade Biosimilar Product and Services Table 134. Synthon Pharmaceuticals Remicade Biosimilar SWOT Analysis Table 135. Synthon Pharmaceuticals Recent Developments Table 136. LG Life Sciences Corporation Information Table 137. LG Life Sciences Description and Overview Table 138. LG Life Sciences Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 139. LG Life Sciences Remicade Biosimilar Product and Services Table 140. LG Life Sciences Remicade Biosimilar SWOT Analysis Table 141. LG Life Sciences Recent Developments Table 142. Novartis (Sandoz) Corporation Information Table 143. Novartis (Sandoz) Description and Overview Table 144. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 145. Novartis (Sandoz) Remicade Biosimilar Product and Services Table 146. Novartis (Sandoz) Remicade Biosimilar SWOT Analysis Table 147. Novartis (Sandoz) Recent Developments Table 148. Celltrion Corporation Information Table 149. Celltrion Description and Overview Table 150. Celltrion Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 151. Celltrion Remicade Biosimilar Product and Services Table 152. Celltrion Remicade Biosimilar SWOT Analysis Table 153. Celltrion Recent Developments Table 154. Biocon Corporation Information Table 155. Biocon Description and Overview Table 156. Biocon Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 157. Biocon Remicade Biosimilar Product and Services Table 158. Biocon Remicade Biosimilar SWOT Analysis Table 159. Biocon Recent Developments Table 160. Hospira Corporation Information Table 161. Hospira Description and Overview Table 162. Hospira Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 163. Hospira Remicade Biosimilar Product and Services Table 164. Hospira Remicade Biosimilar SWOT Analysis Table 165. Hospira Recent Developments Table 166. Merck Serono (Merck Group) Corporation Information Table 167. Merck Serono (Merck Group) Description and Overview Table 168. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 169. Merck Serono (Merck Group) Remicade Biosimilar Product and Services Table 170. Merck Serono (Merck Group) Remicade Biosimilar SWOT Analysis Table 171. Merck Serono (Merck Group) Recent Developments Table 172. Biogen idec Inc. Corporation Information Table 173. Biogen idec Inc. Description and Overview Table 174. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 175. Biogen idec Inc. Remicade Biosimilar Product and Services Table 176. Biogen idec Inc. Remicade Biosimilar SWOT Analysis Table 177. Biogen idec Inc. Recent Developments Table 178. Genentech (Roche Group) Corporation Information Table 179. Genentech (Roche Group) Description and Overview Table 180. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 181. Genentech (Roche Group) Remicade Biosimilar Product and Services Table 182. Genentech (Roche Group) Remicade Biosimilar SWOT Analysis Table 183. Genentech (Roche Group) Recent Developments Table 184. Fosun Pharmaceutical Corporation Information Table 185. Fosun Pharmaceutical Description and Overview Table 186. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 187. Fosun Pharmaceutical Remicade Biosimilar Product and Services Table 188. Fosun Pharmaceutical Remicade Biosimilar SWOT Analysis Table 189. Fosun Pharmaceutical Recent Developments Table 190. Livzon Pharmaceutical Corporation Information Table 191. Livzon Pharmaceutical Description and Overview Table 192. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 193. Livzon Pharmaceutical Remicade Biosimilar Product and Services Table 194. Livzon Pharmaceutical Recent Developments Table 195. Anke Biotechnology Corporation Information Table 196. Anke Biotechnology Description and Overview Table 197. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 198. Anke Biotechnology Remicade Biosimilar Product and Services Table 199. Anke Biotechnology Recent Developments Table 200. Hualan Biological Engineering Corporation Information Table 201. Hualan Biological Engineering Description and Overview Table 202. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 203. Hualan Biological Engineering Remicade Biosimilar Product and Services Table 204. Hualan Biological Engineering Recent Developments Table 205. Walvax Biotechnology Corporation Information Table 206. Walvax Biotechnology Description and Overview Table 207. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 208. Walvax Biotechnology Remicade Biosimilar Product and Services Table 209. Walvax Biotechnology Recent Developments Table 210. Hisun Pharmaceutical Corporation Information Table 211. Hisun Pharmaceutical Description and Overview Table 212. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ml) and Gross Margin (2017-2022) Table 213. Hisun Pharmaceutical Remicade Biosimilar Product and Services Table 214. Hisun Pharmaceutical Recent Developments Table 215. Key Raw Materials Lists Table 216. Raw Materials Key Suppliers Lists Table 217. Remicade Biosimilar Distributors List Table 218. Remicade Biosimilar Customers List Table 219. Research Programs/Design for This Report Table 220. Key Data Information from Secondary Sources Table 221. Key Data Information from Primary Sources List of Figures Figure 1. Remicade Biosimilar Product Picture Figure 2. Global Remicade Biosimilar Sales Market Share by Type in 2021 & 2028 Figure 3. 100mg/10ml Product Picture Figure 4. 500mg/50ml Product Picture Figure 5. Global Remicade Biosimilar Sales Market Share by Application in 2021 & 2028 Figure 6. Blood Disorders Use Case Figure 7. Oncology Diseases Use Case Figure 8. Remicade Biosimilar Report Years Considered Figure 9. Global Remicade Biosimilar Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Remicade Biosimilar Market Size 2017-2028 (US$ Million) Figure 11. Global Remicade Biosimilar Sales (2017-2022) & (L) Figure 12. Global Remicade Biosimilar Market Size Market Share by Region: 2021 VS 2028 Figure 13. Global Remicade Biosimilar Sales Market Share by Region (2017-2022) Figure 14. Global Remicade Biosimilar Sales Market Share by Region in 2021 Figure 15. Global Remicade Biosimilar Revenue Market Share by Region in 2017 VS 2021 Figure 16. Global Remicade Biosimilar Sales Share by Manufacturers in 2021 Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Remicade Biosimilar Sales in 2021 Figure 18. Remicade Biosimilar Revenue Share by Manufacturers in 2021 Figure 19. Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 20. Global Remicade Biosimilar Revenue Share by Type (2017-2022) Figure 21. Global Remicade Biosimilar Revenue Growth Rate by Type in 2017 & 2021 Figure 22. Global Remicade Biosimilar Revenue Share by Application (2017-2022) Figure 23. Global Remicade Biosimilar Revenue Growth Rate by Application in 2017 & 2021 Figure 24. North America Remicade Biosimilar Sales Market Share by Type (2017-2028) Figure 25. North America Remicade Biosimilar Revenue Market Share by Type (2017-2028) Figure 26. North America Remicade Biosimilar Sales Market Share by Application (2017-2028) Figure 27. North America Remicade Biosimilar Revenue Market Share by Application (2017-2028) Figure 28. North America Remicade Biosimilar Sales Share by Country (2017-2028) Figure 29. North America Remicade Biosimilar Revenue Share by Country (2017-2028) Figure 30. United States Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 31. Canada Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 32. Europe Remicade Biosimilar Sales Market Share by Type (2017-2028) Figure 33. Europe Remicade Biosimilar Revenue Market Share by Type (2017-2028) Figure 34. Europe Remicade Biosimilar Sales Market Share by Application (2017-2028) Figure 35. Europe Remicade Biosimilar Revenue Market Share by Application (2017-2028) Figure 36. Europe Remicade Biosimilar Sales Share by Country (2017-2028) Figure 37. Europe Remicade Biosimilar Revenue Share by Country (2017-2028) Figure 38. Germany Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 39. France Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 40. U.K. Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 41. Italy Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 42. Russia Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 43. Asia Pacific Remicade Biosimilar Sales Market Share by Type (2017-2028) Figure 44. Asia Pacific Remicade Biosimilar Revenue Market Share by Type (2017-2028) Figure 45. Asia Pacific Remicade Biosimilar Sales Market Share by Application (2017-2028) Figure 46. Asia Pacific Remicade Biosimilar Revenue Market Share by Application (2017-2028) Figure 47. Asia Pacific Remicade Biosimilar Sales Share by Region (2017-2028) Figure 48. Asia Pacific Remicade Biosimilar Revenue Share by Region (2017-2028) Figure 49. China Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 50. Japan Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 51. South Korea Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 52. India Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 53. Australia Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 54. China Taiwan Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 55. Indonesia Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 56. Thailand Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 57. Malaysia Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 58. Latin America Remicade Biosimilar Sales Market Share by Type (2017-2028) Figure 59. Latin America Remicade Biosimilar Revenue Market Share by Type (2017-2028) Figure 60. Latin America Remicade Biosimilar Sales Market Share by Application (2017-2028) Figure 61. Latin America Remicade Biosimilar Revenue Market Share by Application (2017-2028) Figure 62. Latin America Remicade Biosimilar Sales Share by Country (2017-2028) Figure 63. Latin America Remicade Biosimilar Revenue Share by Country (2017-2028) Figure 64. Mexico Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 65. Brazil Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 66. Argentina Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 67. Middle East and Africa Remicade Biosimilar Sales Market Share by Type (2017-2028) Figure 68. Middle East and Africa Remicade Biosimilar Revenue Market Share by Type (2017-2028) Figure 69. Middle East and Africa Remicade Biosimilar Sales Market Share by Application (2017-2028) Figure 70. Middle East and Africa Remicade Biosimilar Revenue Market Share by Application (2017-2028) Figure 71. Middle East and Africa Remicade Biosimilar Sales Share by Country (2017-2028) Figure 72. Middle East and Africa Remicade Biosimilar Revenue Share by Country (2017-2028) Figure 73. Turkey Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 74. Saudi Arabia Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 75. UAE Remicade Biosimilar Revenue (2017-2028) & (US$ Million) Figure 76. Remicade Biosimilar Value Chain Figure 77. Remicade Biosimilar Production Process Figure 78. Channels of Distribution Figure 79. Distributors Profiles Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed

Synthon Pharmaceuticals LG Life Sciences Novartis (Sandoz) Celltrion Biocon Hospira Merck Serono (Merck Group) Biogen idec Inc. Genentech (Roche Group) Fosun Pharmaceutical Livzon Pharmaceutical Anke Biotechnology Hualan Biological Engineering Walvax Biotechnology Hisun Pharmaceutical